About DAYBUE


Maddy, age 21,
living with Rett
syndrome, with
her family
An opportunity to add more of their sparkle to the world around us
By sparking meaningful improvements in the signs and symptoms of Rett syndrome, DAYBUE® can help illuminate more of the loved one you’ve always known was inside. See the results from the clinical study below.
DAYBUE is the first and only FDA-approved treatment for Rett syndrome in adults and children 2 years of age and older. It is not known if DAYBUE is safe and effective in children under 2 years of age. Over 1700 people living with Rett syndrome have started DAYBUE—including people with a variety of Rett symptoms, girls, boys, and adults.
DAYBUE is not a cure for Rett syndrome.
How was DAYBUE studied?
Caregivers and doctors evaluated changes in the signs and symptoms of Rett syndrome in the LAVENDER™ study
Because caregivers possess such a deep knowledge of their loved one, they contributed directly to the evaluation of the overall effectiveness of DAYBUE. Doctors evaluated if patients improved or got worse, while caregivers looked for changes in the signs and symptoms of Rett syndrome.

Caregivers used the Rett Syndrome Behaviour Questionnaire (RSBQ) to evaluate changes in the signs and symptoms of Rett syndrome.

Doctors used the Clinical Global Impression-Improvement (CGI-I) scale to evaluate if Rett symptoms had improved or worsened.
Expand to see study design
The effectiveness and safety of DAYBUE were evaluated in the 12-week LAVENDER clinical study of 187 female patients aged 5 to 20 with Rett syndrome
Study results
Caregivers evaluated changes in a range of symptoms using the RSBQ
RSBQ is a behavior questionnaire completed by caregivers to evaluate the range of symptoms of Rett syndrome.
What does the RSBQ measure?
Breathing
Hand movements or stereotypies

Repetitive behaviors

Nighttime behaviors
Vocalizations

Facial expressions

Eye gaze
Mood
Understanding RSBQ
Caregivers evaluated 45 items on the RSBQ. Each item was scored as not true (0), somewhat or sometimes true (1), or very true or often true (2)
The scores were added up to determine the RSBQ total score across symptoms
Researchers looked at the change in average RSBQ total score from the start of the study to measure how DAYBUE impacted the signs and symptoms of Rett at Week 12 when compared to patients receiving placebo
At 12 weeks, caregivers observed:
Significant improvements
in the signs and symptoms of Rett syndrome as measured by average change in RSBQ
total score with DAYBUE vs placebo
At 12 weeks, the group of patients receiving DAYBUE (n=76) saw a decrease of 4.9 in average RSBQ total score from the start of the study when compared with a decrease of 1.7 in the placebo group (n=85), meaning an improvement in Rett symptoms
The difference between the two groups was -3.2. A lower score meant signs and symptoms of Rett syndrome were less severe
Before starting treatment, the average RSBQ total score for the DAYBUE group was 43.7. For the placebo group, the average RSBQ total score before treatment was 44.5
Results varied between patients in the clinical study. The effect of DAYBUE on individual symptoms measured by RSBQ has not been shown. Individual results may vary with DAYBUE
What improvements could DAYBUE help spark?
Caregiver’s description of improvements with DAYBUE:
Important Notes:
In the clinical study, individual response varied. Some patients had minimal to no improvements with DAYBUE
These patients were also receiving other types of therapy, like physical, occupational, or speech therapy
Some of these patients experienced side effects, including diarrhea, behavioral issues, or gas. See the full stories to learn more about their DAYBUE experiences
Always speak with a healthcare provider to learn what to expect when starting DAYBUE, including side effects
The families featured here were compensated for sharing their stories and participating in photo shoots. These stories were created in 2024


Learn from caregivers and their individual loved one’s experience with DAYBUE
Clare, age 9, living with Rett syndrome, with her mom
At 12 weeks, doctors observed:
Significant improvements in the signs and symptoms of Rett syndrome in patients taking DAYBUE vs placebo
The CGI-I (Clinical Global Impression-Improvement) scale was used by doctors to evaluate improvement or worsening of Rett symptoms.
38% of patients (n=77) had improvement in symptoms with DAYBUE vs 15% of patients (n=86) on placebo
Much improved (13% vs 5% for placebo), minimally improved (25% vs 10%)
61% of patients had no improvements in symptoms with DAYBUE vs 81% of patients taking placebo
Important Note: Because each individual with Rett syndrome is unique—with a unique set of symptoms—improvements with DAYBUE may be different for everyone.


Do you have questions about treatment with DAYBUE?
While treatment with DAYBUE is a decision you and your loved one’s doctor can make, Family Support Educators can help answer your questions about Rett syndrome, comprehensive care, and connecting with other caregivers.
Lara, Family Support Educator
Understanding the possible GI side effects of DAYBUE
As with any medication, it’s important to talk to your loved one’s doctor about the possibility of side effects with DAYBUE. Not every person will experience the same side effects, and for some people, certain side effects, such as diarrhea and vomiting, may be more severe than others.
Side effects may include:

Diarrhea:
Diarrhea is a common side effect of DAYBUE that can sometimes be severe. Diarrhea may cause your child to lose too much water from their body (dehydration). Before starting treatment with DAYBUE, stop taking laxatives. Tell your doctor if your child has diarrhea while taking DAYBUE. Your doctor may ask you to increase the amount your child drinks or give antidiarrheal medicine as needed.
Vomiting:
Vomiting is a common side effect of DAYBUE. Sometimes vomit can get into your child's lungs (aspiration), which could cause an infection (aspiration pneumonia). Tell your doctor if they have severe vomiting or if vomiting happens often.

Weight loss:
DAYBUE can cause weight loss. Tell your doctor if you notice your child is losing weight at any time during treatment with DAYBUE.
Learn how to help manage possible side effects
Is DAYBUE right for your child?

The DAYBUE Overview Brochure provides information about DAYBUE clinical study results, safety facts, caregiver experiences, and helpful treatment tips.

The DAYBUE Treatment Discussion Guide is a tool you can use to talk to your loved one’s doctor about DAYBUE.
Support by your side
Acadia Connect is a patient and family support program that connects you and your family with educational support and resources throughout the DAYBUE treatment journey.
Call Acadia Connect at 1-844-737-2223, Monday to Friday, 8








